Log in to your account:
Seattle Genetics (SGEN) PT Raised to $165 at Stifel After Considering Merck Contribution
September 22, 2020 6:44 AM
Stifel analyst Stephen Willey raised the price target on Seattle Genetics (NASDAQ: SGEN) to $165.00 (from $145.00) after updating the ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Analyst PT Change